Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1996 Jun;73(11):1366–1372. doi: 10.1038/bjc.1996.260

Monoclonal antibody against the fusion junction of a deletion-mutant epidermal growth factor receptor.

S Okamoto 1, K Yoshikawa 1, Y Obata 1, M Shibuya 1, S Aoki 1, J Yoshida 1, T Takahashi 1
PMCID: PMC2074493  PMID: 8645581

Abstract

A mouse monoclonal antibody (IgG2b), 3C10, was produced against the truncated epidermal growth factor receptor (EGFR), encoded by the (type III) in-frame deletion mutation of 801 nucleotides of EGFR affecting the external domain, known to be expressed in some human glioblastoma. As this mutation newly generates a glycine residue at the fusion point, a 14 amino acid peptide around the fusion junction including this glycine was chemically synthesised and used for immunisation of (B6 x DBA/2) F1 mice. Flow cytometric analysis showed 3C10 antibody staining of a mouse NIH/3T3 transfectant (ERM5) with the type III EGFR deletion-mutant gene, but not one with wild-type EGFR. The antibody immunoprecipitated the truncated EGFR protein with a molecular mass of approximately 140 kDa from ERM5 cells. Immunostaining of glioblastomas revealed binding in the case with the type III EGFR mutation, the five other specimens without the mutation being negative despite overexpression of EGFR in some cases.

Full text

PDF
1366

Images in this article

1368Figure 5
on p.1368
1369Figure 6
on p.1369
1370Figure 7
on p.1370
1370Figure 8
on p.1370
1370Figure 9
on p.1370

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baba E., Nakamura M., Ohkuma K., Kira J., Tanaka Y., Nakano S., Niho Y. A peptide-based human T cell leukemia virus type I vaccine containing T and B cell epitopes that induces high titers of neutralizing antibodies. J Immunol. 1995 Jan 1;154(1):399–412. [PubMed] [Google Scholar]
  2. Bergerheim U., Nordenskjöld M., Collins V. P. Deletion mapping in human renal cell carcinoma. Cancer Res. 1989 Mar 15;49(6):1390–1396. [PubMed] [Google Scholar]
  3. Bigner S. H., Humphrey P. A., Wong A. J., Vogelstein B., Mark J., Friedman H. S., Bigner D. D. Characterization of the epidermal growth factor receptor in human glioma cell lines and xenografts. Cancer Res. 1990 Dec 15;50(24):8017–8022. [PubMed] [Google Scholar]
  4. Carey T. E., Takahashi T., Resnick L. A., Oettgen H. F., Old L. J. Cell surface antigens of human malignant melanoma: mixed hemadsorption assays for humoral immunity to cultured autologous melanoma cells. Proc Natl Acad Sci U S A. 1976 Sep;73(9):3278–3282. doi: 10.1073/pnas.73.9.3278. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Carpenter G. Receptors for epidermal growth factor and other polypeptide mitogens. Annu Rev Biochem. 1987;56:881–914. doi: 10.1146/annurev.bi.56.070187.004313. [DOI] [PubMed] [Google Scholar]
  6. Ekstrand A. J., Sugawa N., James C. D., Collins V. P. Amplified and rearranged epidermal growth factor receptor genes in human glioblastomas reveal deletions of sequences encoding portions of the N- and/or C-terminal tails. Proc Natl Acad Sci U S A. 1992 May 15;89(10):4309–4313. doi: 10.1073/pnas.89.10.4309. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Fagraeus A., Espmark J. A., Jonsson J. Mixed haemadsorption: a mixed antiglobulin reaction applied to antigens on a glass surface. Preparation and evaluation of indicator red cells; survey of present applications. Immunology. 1965 Aug;9(2):161–175. [PMC free article] [PubMed] [Google Scholar]
  8. Garcia de Palazzo I. E., Adams G. P., Sundareshan P., Wong A. J., Testa J. R., Bigner D. D., Weiner L. M. Expression of mutated epidermal growth factor receptor by non-small cell lung carcinomas. Cancer Res. 1993 Jul 15;53(14):3217–3220. [PubMed] [Google Scholar]
  9. Humphrey P. A., Gangarosa L. M., Wong A. J., Archer G. E., Lund-Johansen M., Bjerkvig R., Laerum O. D., Friedman H. S., Bigner D. D. Deletion-mutant epidermal growth factor receptor in human gliomas: effects of type II mutation on receptor function. Biochem Biophys Res Commun. 1991 Aug 15;178(3):1413–1420. doi: 10.1016/0006-291x(91)91051-d. [DOI] [PubMed] [Google Scholar]
  10. Humphrey P. A., Wong A. J., Vogelstein B., Friedman H. S., Werner M. H., Bigner D. D., Bigner S. H. Amplification and expression of the epidermal growth factor receptor gene in human glioma xenografts. Cancer Res. 1988 Apr 15;48(8):2231–2238. [PubMed] [Google Scholar]
  11. Humphrey P. A., Wong A. J., Vogelstein B., Zalutsky M. R., Fuller G. N., Archer G. E., Friedman H. S., Kwatra M. M., Bigner S. H., Bigner D. D. Anti-synthetic peptide antibody reacting at the fusion junction of deletion-mutant epidermal growth factor receptors in human glioblastoma. Proc Natl Acad Sci U S A. 1990 Jun;87(11):4207–4211. doi: 10.1073/pnas.87.11.4207. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. James C. D., Carlbom E., Dumanski J. P., Hansen M., Nordenskjold M., Collins V. P., Cavenee W. K. Clonal genomic alterations in glioma malignancy stages. Cancer Res. 1988 Oct 1;48(19):5546–5551. [PubMed] [Google Scholar]
  13. Kikuchi T., Takahashi M., Ueda R., Ohba M., Seito T., Hiai H., Nakashima I., Takahashi T. Nuclear localization of antigens detected by a monoclonal antibody against a synthetic peptide of rfp finger protein. Hybridoma. 1990 Apr;9(2):189–200. doi: 10.1089/hyb.1990.9.189. [DOI] [PubMed] [Google Scholar]
  14. Kurata A., Palker T. J., Streilein R. D., Scearce R. M., Haynes B. F., Berzofsky J. A. Immunodominant sites of human T cell lymphotropic virus type 1 envelope protein for murine helper T cells. J Immunol. 1989 Sep 15;143(6):2024–2030. [PubMed] [Google Scholar]
  15. Libermann T. A., Razon N., Bartal A. D., Yarden Y., Schlessinger J., Soreq H. Expression of epidermal growth factor receptors in human brain tumors. Cancer Res. 1984 Feb;44(2):753–760. [PubMed] [Google Scholar]
  16. Nielsen B., Borup-Christensen P., Erb K., Jensenius J. C., Husby S. A method for the blocking of endogenous immunoglobulin on frozen tissue sections in the screening of human hybridoma antibody in culture supernatants. Hybridoma. 1987 Feb;6(1):103–109. doi: 10.1089/hyb.1987.6.103. [DOI] [PubMed] [Google Scholar]
  17. Rammensee H. G., Friede T., Stevanoviíc S. MHC ligands and peptide motifs: first listing. Immunogenetics. 1995;41(4):178–228. doi: 10.1007/BF00172063. [DOI] [PubMed] [Google Scholar]
  18. Seto M., Takahashi T., Tanimoto M., Nishizuka Y. Production of monoclonal antibodies against MM antigen: the serologic identification of MM antigen with Ly-6.2 alloantigen. J Immunol. 1982 Jan;128(1):201–205. [PubMed] [Google Scholar]
  19. Sugawa N., Ekstrand A. J., James C. D., Collins V. P. Identical splicing of aberrant epidermal growth factor receptor transcripts from amplified rearranged genes in human glioblastomas. Proc Natl Acad Sci U S A. 1990 Nov;87(21):8602–8606. doi: 10.1073/pnas.87.21.8602. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Ueda R., Nishida K., Koide Y., Tsuge I., Seto M., Yoshida M., Miyoshi I., Ota K., Takahashi T. Two mouse monoclonal antibodies detecting two different epitopes of an activated lymphocyte antigen on adult T-cell leukemia cells. Cancer Res. 1985 Mar;45(3):1314–1319. [PubMed] [Google Scholar]
  21. Ullrich A., Coussens L., Hayflick J. S., Dull T. J., Gray A., Tam A. W., Lee J., Yarden Y., Libermann T. A., Schlessinger J. Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells. 1984 May 31-Jun 6Nature. 309(5967):418–425. doi: 10.1038/309418a0. [DOI] [PubMed] [Google Scholar]
  22. Waterfield M. D., Mayes E. L., Stroobant P., Bennet P. L., Young S., Goodfellow P. N., Banting G. S., Ozanne B. A monoclonal antibody to the human epidermal growth factor receptor. J Cell Biochem. 1982;20(2):149–161. doi: 10.1002/jcb.240200207. [DOI] [PubMed] [Google Scholar]
  23. Wikstrand C. J., Hale L. P., Batra S. K., Hill M. L., Humphrey P. A., Kurpad S. N., McLendon R. E., Moscatello D., Pegram C. N., Reist C. J. Monoclonal antibodies against EGFRvIII are tumor specific and react with breast and lung carcinomas and malignant gliomas. Cancer Res. 1995 Jul 15;55(14):3140–3148. [PubMed] [Google Scholar]
  24. Wikstrand C. J., Stanley S. D., Humphrey P. A., Pegram C. N., Archer G. E., Kurpad S., Shibuya M., Bigner D. D. Investigation of a synthetic peptide as immunogen for a variant epidermal growth factor receptor associated with gliomas. J Neuroimmunol. 1993 Jul;46(1-2):165–173. doi: 10.1016/0165-5728(93)90246-u. [DOI] [PubMed] [Google Scholar]
  25. Wong A. J., Bigner S. H., Bigner D. D., Kinzler K. W., Hamilton S. R., Vogelstein B. Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification. Proc Natl Acad Sci U S A. 1987 Oct;84(19):6899–6903. doi: 10.1073/pnas.84.19.6899. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Wong A. J., Ruppert J. M., Bigner S. H., Grzeschik C. H., Humphrey P. A., Bigner D. S., Vogelstein B. Structural alterations of the epidermal growth factor receptor gene in human gliomas. Proc Natl Acad Sci U S A. 1992 Apr 1;89(7):2965–2969. doi: 10.1073/pnas.89.7.2965. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Yamazaki H., Fukui Y., Ueyama Y., Tamaoki N., Kawamoto T., Taniguchi S., Shibuya M. Amplification of the structurally and functionally altered epidermal growth factor receptor gene (c-erbB) in human brain tumors. Mol Cell Biol. 1988 Apr;8(4):1816–1820. doi: 10.1128/mcb.8.4.1816. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Yamazaki H., Ohba Y., Tamaoki N., Shibuya M. A deletion mutation within the ligand binding domain is responsible for activation of epidermal growth factor receptor gene in human brain tumors. Jpn J Cancer Res. 1990 Aug;81(8):773–779. doi: 10.1111/j.1349-7006.1990.tb02644.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Yoshikawa K., Furukawa K., Ueda R., Iwasa S., Lloyd K. O., Notake K., Takahashi T. A human monoclonal antibody recognizing a surface antigen on stomach cancer cells. Jpn J Cancer Res. 1989 Jun;80(6):546–553. doi: 10.1111/j.1349-7006.1989.tb01674.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Yoshikawa K., Ueda R., Obata Y., Utsumi K. R., Notake K., Takahashi T. Human monoclonal antibody reactive to stomach cancer produced by mouse-human hybridoma technique. Jpn J Cancer Res. 1986 Nov;77(11):1122–1133. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES